« Back to Record
Citation APA

Stopeck, A., Tonkin, K., Shore, N., Sieber, P., Kueppers, F., Karsh, L., Yardley, D., Wang, H., Maniar, T., Arellano, J., Braun, A., Fizazi, K., Body, J.-J., Brown, J., Carducci, M., Diel, I. J., Fujiwara, Y., Martin, M., & Paterson, A. H. G. (2016). Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Supportive care in cancer, 24(1), 447-455. doi:10.1007/s00520-015-2904-5


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/227089

Stopeck, A., Tonkin, K., Shore, N., Sieber, P., Kueppers, F., Karsh, L., Yardley, D., Wang, H., Maniar, T., Arellano, J., Braun, A., Fizazi, K., Body, J.-J., Brown, J., Carducci, M., Diel, I. J., Fujiwara, Y., Martin, M., & Paterson, A. H. G. (2016). Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Supportive care in cancer, 24(1), 447-455. doi:10.1007/s00520-015-2904-5